Page 84 | Certara

On-Demand Webinar

AAPS eChalk Talk: Pharmacokinetic Modeling & Scientific Communications Expertise Advances Sarcoidosis Drug Program

The development of new drugs for rare diseases is a challenging process due to small…

CertaraOctober 12, 2023

Press Release

Certara to Report Third Quarter 2023 Financial Results on November 8th, 2023, and participate in the Stephens Annual Investment Conference

PRINCETON, N.J, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader…

CertaraOctober 11, 2023

Publication

Regulatory initiatives for artificial intelligence applications: Regulatory writing implications

Medical Writing | Volume 32, Issue 3 - Artificial Intelligence and Machine LearningAuthor: Anjana Bose…

CertaraOctober 11, 2023

Announcement

Certara Acquires Formedix LLC to Increase Data Standardization Across Clinical Trials for Faster Study Setup, Time to Analysis and Submissions

Formedix ryze cloud based clinical metadata repository and SDTM automation suite and Certara Pinnacle 21…

CertaraOctober 10, 2023

Blog

Do the Scale-up & Post approval Changes (SUPAC) Guidance Documents Still Apply to Drug Developers?

Do you remember the 1990s? The Soviet Union fell, Friends was the most popular TV…

CertaraOctober 6, 2023

Conference

GMP 2024 Symposium

CertaraOctober 5, 2023

Announcement

Certara Introduces Certara.AI, the Life Sciences Specialized GPT Platform

Certara.AI Improves Drug Research & Development Processes with Secure, Client-Specific, A.I. Applications PRINCETON, N. J.—October…

CertaraOctober 5, 2023

Publication

Analysis of clinical failure of anti-tau and anti-synuclein antibodies in neurodegeneration using a quantitative systems pharmacology model

Hugo Geerts, Silke Bergeler, Mike Walker, Piet van der Graaf, Jean-Philippe Courade. Sci Rep. 2023…

CertaraOctober 5, 2023

Press Coverage

How Modeling Can Help to Improve Children’s Access to Properly Evaluated Medications

Regulatory guidance paves the way to address ethical concerns in pediatric trials, and how additional…

CertaraOctober 5, 2023

On-Demand Webinar

Clinical Pharmacology Issues That Can Lead to Approvability Problems for Your Drug

Clinical pharmacology information comprises more than 50% of a drug label. Inadequate clinical pharmacology development…

CertaraOctober 4, 2023

AAPS eChalk Talk: Pharmacokinetic Modeling & Scientific Communications Expertise Advances Sarcoidosis Drug Program

Certara to Report Third Quarter 2023 Financial Results on November 8th, 2023, and participate in the Stephens Annual Investment Conference

Regulatory initiatives for artificial intelligence applications: Regulatory writing implications

Certara Acquires Formedix LLC to Increase Data Standardization Across Clinical Trials for Faster Study Setup, Time to Analysis and Submissions

Do the Scale-up & Post approval Changes (SUPAC) Guidance Documents Still Apply to Drug Developers?

GMP 2024 Symposium

Certara Introduces Certara.AI, the Life Sciences Specialized GPT Platform

Analysis of clinical failure of anti-tau and anti-synuclein antibodies in neurodegeneration using a quantitative systems pharmacology model

How Modeling Can Help to Improve Children’s Access to Properly Evaluated Medications

Clinical Pharmacology Issues That Can Lead to Approvability Problems for Your Drug

Newsletter sign up

Quick links

Solutions

Contact